Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers.

Author: Hooshmand-RadR, LibermanA, MarmonT, PencekR, RothJ D, YoungM A

Paper Details 
Original Abstract of the Article :
The bile acid analogue obeticholic acid (OCA) is a selective farnesoid X receptor (FXR) agonist in development for treatment of several chronic liver diseases. FXR activation regulates lipoprotein homeostasis. The effects of OCA on cholesterol and lipoprotein metabolism in healthy individuals were a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/dom.12681

データ提供:米国国立医学図書館(NLM)

Obeticholic Acid's Effects on Lipoprotein Metabolism in Healthy Volunteers

This research examines the effects of obeticholic acid (OCA), a selective farnesoid X receptor (FXR) agonist, on lipoprotein metabolism in healthy individuals. The researchers conducted two phase I studies to evaluate the impact of repeated oral doses of OCA on lipid variables, including cholesterol and lipoprotein levels. Their findings provide valuable insights into the potential impact of OCA on lipid profiles, particularly in the context of its use for treating chronic liver diseases.

Obeticholic Acid's Impact on HDL and LDL Cholesterol

The study found that OCA significantly altered circulating cholesterol and lipoprotein levels in healthy individuals. The researchers observed a decrease in HDL cholesterol and an increase in LDL cholesterol, suggesting potential implications for cardiovascular health. These findings highlight the need for careful monitoring of lipid profiles in patients receiving OCA, particularly those with pre-existing cardiovascular risk factors.

Navigating the Potential Risks and Benefits of Obeticholic Acid

This study underscores the importance of weighing the potential risks and benefits of OCA when considering its use for treating chronic liver diseases. While OCA may offer promising benefits in treating liver conditions, its potential impact on lipid profiles warrants careful monitoring and consideration. The researchers' findings emphasize the need for continued research into the long-term cardiovascular effects of OCA, ensuring that patients receive the safest and most effective treatments.

Dr. Camel's Conclusion

This research reminds us that even in the vast and sometimes unpredictable desert of pharmaceutical research, there are oases of knowledge. Understanding the complex interplay between medications and lipid metabolism is crucial for developing safe and effective treatments, ensuring that patients receive the best possible care while minimizing potential risks.

Date :
  1. Date Completed 2017-10-31
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27109453

DOI: Digital Object Identifier

10.1111/dom.12681

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.